Literature DB >> 11439240

An animal model of nicotinic-acid-induced vasodilation: effect of haloperidol, caffeine and nicotine upon nicotinic acid response.

S D Turenne1, M Seeman, B M Ross.   

Abstract

BACKGROUND: The normal vasodilatory response to ingestion of nicotinic acid (NA) is impaired in some patients with schizophrenia. It is unclear whether the impairment is a feature of the disorder itself or to a confounding factor such as neuroleptics, caffeine or nicotine use.
METHODS: To address this question in a controlled manner, we have developed an animal (rat) model of NA-induced vasodilation, in which response is monitored by measuring change in skin temperature.
RESULTS: We observed that (i) acute administration of acetylsalicylic acid (100mg/kg), caffeine (2.5mg/kg) and haloperidol (0.1 or 0.5mg/kg) and (ii) chronic administration of haloperidol (0.2mg/kg/day) significantly inhibited NA (30 mg/kg) response, whereas neither acute (0.25mg/kg) or chronic (0.5mg/kg/day for 14 days) administration of nicotine, or chronic administration of caffeine (5mg/kg/day for 14 days) had any significant effect upon NA response.
CONCLUSIONS: Our data suggest that at least one drug commonly used to treat schizophrenia (haloperidol) can interfere with the vasodilatory response to NA. Studies using non-medicated patients with schizophrenia are required to determine whether reduced vasodilatory response to NA in schizophrenia is a feature of the disorder or a consequence of treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439240     DOI: 10.1016/s0920-9964(00)00082-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  Urotensin-II induces ear flushing in rats.

Authors:  J-s Qi; R Schulingkamp; T J Parry; R Colburn; D Stone; B Haertlein; L K Minor; P Andrade-Gordon; B P Damiano
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

2.  Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives.

Authors:  Sheng-Hsiang Lin; Chih-Min Liu; Shu-Sen Chang; Hai-Gwo Hwu; Shi K Liu; Tzung J Hwang; Ming-Hsien Hsieh; Shi-Chin Guo; Wei J Chen
Journal:  Schizophr Bull       Date:  2006-08-25       Impact factor: 9.306

3.  Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.

Authors:  Kang Cheng; Tsuei-Ju Wu; Kenneth K Wu; Claudio Sturino; Kathleen Metters; Keith Gottesdiener; Samuel D Wright; Zhaoyin Wang; Gary O'Neill; Eseng Lai; M Gerard Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

4.  The flavonoid luteolin inhibits niacin-induced flush.

Authors:  D Papaliodis; W Boucher; D Kempuraj; T C Theoharides
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

5.  Nicotinic acid promotes sleep through prostaglandin synthesis in mice.

Authors:  Éva Szentirmai; Levente Kapás
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

6.  Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading.

Authors:  Shu-Sen Chang; Chih-Min Liu; Sheng-Hsiang Lin; Hai-Gwo Hwu; Tzung J Hwang; Shi K Liu; Ming H Hsieh; Shi-Chin Guo; Wei J Chen
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.